Newsroom

Sorted by: Latest

-

Mundys S.p.A. UK Regulatory Announcement: Mundys Strengthens Its Strategic Position in Getlink

ROME--(BUSINESS WIRE)--  Regulatory News: Mundys today announces that it strengthens its strategic position in Getlink with the acquisition1 of up to 9.5% of Getlink share capital. 3.5% of Getlink’s share capital will be acquired upfront, with the ability for Mundys to acquire up to an additional 6.0% conditional upon Mundys receiving the required regulatory approval, expected by April 20262. As a result of acquiring 3.5% of Getlink’s shares, Mundys will hold 19.0% of Getlink’s share capital an...
-

AviadoBio Advances AVB-101 Gene Therapy Program and Initiates Fourth Dose-Escalation Cohort of Phase 1/2 ASPIRE-FTD Trial

LONDON--(BUSINESS WIRE)--AviadoBio Advances AVB-101 Gene Therapy Program and Initiates Fourth Dose-Escalation Cohort of Phase 1/2 ASPIRE-FTD Trial...
-

TotalEnergies SE UK Regulatory Announcement: Transaction in Own Shares

PARIS--(BUSINESS WIRE)--  In accordance with the authorizations given by the shareholders’ general meeting on May 23, 2025, to trade on its shares and pursuant to applicable law on share repurchase, TotalEnergies SE (LEI: 529900S21EQ1BO4ESM68) (Paris:TTE) (LSE:TTE) (NYSE:TTE) declares the following purchases of its own shares (FR0000120271) from March 23 to March 27, 2026: Transaction Date Total daily volume (number of shares) Daily weighted average purchase price of shares (EUR/share) Amount o...
-

Inter-American Development Bank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: Inter-American Development Bank USD 500,000,000.00 MATURING: 04-Oct-2027 ISIN: US4581X0EG91 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 05-Jan-2026 TO 06-Apr-2026 HAS BEEN FIXED AT 4.03 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 06-Apr-2026 WILL AMOUNT TO: USD 10.20 PER USD 1,000.00 DENOMINATION  ...
-

TotalEnergies SE UK Regulatory Announcement: Director/PDMR Shareholding

PARIS--(BUSINESS WIRE)--  TotalEnergies SE has received a notification of dealing from a Person Discharging Managerial Responsibilities (“PDMR”). The notification of dealing form can be found below. This notification is made in accordance with the UK Market Abuse Regulation. About TotalEnergies TotalEnergies is a global integrated energy company that produces and markets energies: oil and biofuels, natural gas, biogas and low-carbon hydrogen, renewables and electricity. Our more than 100,000 em...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: SNB FUNDING LIMITED AUD 20,000,000.00 MATURING: 30-Mar-2033 ISIN: XS2606316599 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 30-Mar-2026 TO 30-Jun-2026 HAS BEEN FIXED AT 6.13 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 30-Jun-2026 WILL AMOUNT TO: AUD 3,087.77 PER AUD 200,000.00 DENOMINATION  ...
-

TotalEnergies SE : Déclaration des Transactions sur Actions Propres

PARIS--(BUSINESS WIRE)--Regulatory News: Dans le cadre des autorisations consenties par l’Assemblée générale du 23 mai 2025 pour opérer sur ses actions et conformément à la réglementation relative aux rachats d'actions, TotalEnergies SE (LEI : 529900S21EQ1BO4ESM68) (Paris:TTE) (LSE:TTE) (NYSE:TTE) déclare ci-après les achats d’actions propres (FR0000120271) réalisés du 23 mars au 27 mars 2026 : Jour de la transaction Volume total journalier (en nombre de titres) Prix pondéré moyen journalier d'...
-

Regnology Announces Next-Generation Ascend Platform with Agentic AI, Advancing the Future of Regulatory Reporting

FRANKFURT, Germany--(BUSINESS WIRE)--Regnology introduces RSH Ascend as an agentic‑first milestone on the Ascend platform, strengthening supervisory insight toward STR....
-

Signadori Bio appoints Dr. Selwyn Ho, MB BS as Chief Executive Officer to lead company into next stage of growth

PARIS--(BUSINESS WIRE)--Signadori Bio, a preclinical-stage biopharmaceutical company developing a next generation, off-the shelf, in vivo engineered, monocyte immunotherapy platform to treat solid tumours, today announced the appointment of Dr. Selwyn Ho as Chief Executive Officer. Dr. Ho is an experienced biopharma and biotech executive, with nearly 30 years of experience across commercialisation, drug development and multiple pre-& post-product launches, with a focus in ophthalmology, imm...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: Catalyst Healthcare (Romford) GBP 118,400,000.00 MATURING: 30-Sep-2038 ISIN: XS0184015336 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 31-Mar-2026 TO 30-Sep-2026 HAS BEEN FIXED AT 6.68 PCT DAY BASIS: ACTUAL/ACTUAL(ISMA) INTEREST PAYABLE VALUE 30-Sep-2026 WILL AMOUNT TO: GBP 932.39 PER GBP 27,909.85 DENOMINATION  ...